Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 250 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-07-08 | 2022-10-18 | 142201 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Resolved | 2021-10-21 | 2022-10-18 | 147717 |
| TEVA-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2022-06-30 | 2022-10-18 | 163951 |
| TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2022-06-30 | 2022-10-18 | 163954 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Resolved | 2022-07-25 | 2022-10-18 | 165459 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-08-18 | 2022-10-18 | 167153 |
| TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-09-30 | 2022-10-18 | 170776 |
| TEVA-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-08-18 | 2022-10-29 | 167226 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-04-21 | 2022-10-29 | 159186 |
| TEVA-MORPHINE SR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-05-12 | 2022-10-29 | 160448 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 1MG | SOLUTION | Resolved | 2022-06-16 | 2022-10-29 | 162858 |
| TEVA-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-08-18 | 2022-10-29 | 167221 |
| TEVA-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2022-09-30 | 2022-10-29 | 170764 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-01-27 | 2022-11-12 | 153709 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2022-01-27 | 2022-11-12 | 153733 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2022-04-21 | 2022-11-12 | 159198 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-05-12 | 2022-11-12 | 160427 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-05-12 | 2022-11-12 | 160432 |
| TEVA-TAMOXIFEN | 10MG | TABLET | Resolved | 2022-06-09 | 2022-11-12 | 162306 |
| TEVA-SUMATRIPTAN DF | 25MG | TABLET | Resolved | 2022-10-28 | 2022-11-12 | 173028 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |